- Comparative efficacy of first-line antiseizure monotherapy in pediatric focal epilepsy: An umbrella review of systematic reviews and meta-analyses. [Review]Epileptic Disord. 2026 Oct 28. [Online ahead of print]ED
- CONCLUSIONS: Current umbrella-level evidence does not establish clear superiority of one first-line ASM over another for seizure control in pediatric focal epilepsy. Importantly, the absence of statistically significant differences should not be interpreted as evidence of therapeutic equivalence, because several estimates remain imprecise and clinically meaningful differences cannot be excluded. Interpretation is further limited by the scarcity of pediatric-specific comparative data, the frequent inclusion of mixed-age populations, and methodological and outcome heterogeneity across reviews. Safety and tolerability should therefore be considered alongside efficacy when individualizing treatment selection. Well-designed pediatric-specific comparative studies using standardized outcome measures are needed to strengthen evidence-based treatment recommendations.
- Publisher Full Text (DOI)
- Reply to: Considerations for tracking cognitive trajectories after epilepsy surgery using the international classification of cognitive disorders in epilepsy (IC-CoDE). [Letter]Epileptic Disord. 2026 Oct 28. [Online ahead of print]ED
- Publisher Full Text (DOI)
- Rethinking pediatric epilepsy management: From household environment to a family-centered Mediterranean lifestyle intervention. [Letter]Epileptic Disord. 2026 Oct 27. [Online ahead of print]ED
- Publisher Full Text (DOI)
- The ongoing dilemma of immunotherapy in antibody-negative suspected autoimmune encephalitis-associated epilepsy: A retrospective cohort study. [Journal Article]Epileptic Disord. 2026 Oct 27. [Online ahead of print]ED
- CONCLUSIONS: The study reveals IMT has limited success in patients with DRE and concern for AEAE but Ab-. Critical evaluation of IMT is essential in suspected AEAE cases with Ab- to avoid unnecessary administration of potentially hazardous immunotherapy in patients who are unlikely to benefit.
- Publisher Full Text (DOI)
- Mediterranean dietary patterns and epilepsy: Distinguishing nutritional benefits from antiseizure efficacy. [Letter]Epileptic Disord. 2026 Oct 27. [Online ahead of print]ED
- Publisher Full Text (DOI)
- Atmospheric pressure, temperature, and online search activity for epilepsy: A daily time-series study. [Journal Article]Epileptic Disord. 2026 Oct 22. [Online ahead of print]ED
- CONCLUSIONS: Lower mean sea-level pressure was associated with increased population-level epilepsy-related Google search activity. The observed association corresponded to a 13.3-hPa reduction in atmospheric pressure, a difference commonly encountered during the passage of low-pressure weather systems. Although the direction of the association is broadly consistent with some studies reporting increased seizure occurrence during periods of lower atmospheric pressure, Google Trends reflects information-seeking behavior rather than clinical outcomes. Therefore, these findings should be regarded as hypothesis-generating and should not be interpreted as evidence that atmospheric pressure influences seizure occurrence.
- Publisher Full Text (DOI)
- Empagliflozin in Lafora disease: A first-in-human 6-month pilot study with electroclinical and FDG-PET findings. [Journal Article]Epileptic Disord. 2026 Oct 16. [Online ahead of print]ED
- CONCLUSIONS: In this first-in-human, 6-month pilot study, empagliflozin showed acceptable short-term safety and feasibility in LD, but no definitive conclusions on efficacy can be drawn. The dissociation between relative electroclinical stability and progressive metabolic impairment suggests that quantitative FDG-PET may represent a sensitive biomarker for monitoring disease trajectory in this ultra-rare epilepsy.
- Publisher Full Text (DOI)
- Resective epilepsy surgery in an adult with ARID1B-related disorder and focal cortical dysplasia type IIb. [Case Reports]Epileptic Disord. 2026 Oct 15. [Online ahead of print]ED
- Publisher Full Text (DOI)
- Affective symptoms in focal epilepsy: A scoping review of localization and lateralizing findings. [Review]Epileptic Disord. 2026 Oct 14. [Online ahead of print]ED
- Emotional experiences during focal seizures are often misinterpreted as psychiatric disorders. We aimed to evaluate symptoms involving affective symptoms at seizure onset. We aimed to identify the most prevalent affective symptoms at seizure onset and characterize their localizing and lateralizing value. We performed a scoping review based on Preferred Reporting Items for Systematic reviews and M…
- Publisher Full Text (DOI)
- Chronic phenytoin toxicity presenting with asterixis, cerebellar signs, and encephalopathy. [Journal Article]Epileptic Disord. 2026 Oct 13. [Online ahead of print]ED
- Publisher Full Text (DOI)
- An interview with Ahmed Gaballa, the 2026 Epileptic Disorders prize winner. [Editorial]Epileptic Disord. 2026 Oct 13. [Online ahead of print]ED
- Publisher Full Text (DOI)
- Development and external validation of a nomogram for predicting in-hospital mortality in status epilepticus patients in the intensive care unit: A MIMIC-IV and eICU-CRD study. [Journal Article]Epileptic Disord. 2026 Oct 13. [Online ahead of print]ED
- CONCLUSIONS: This nine-variable nomogram provides a validated, bedside-applicable tool for mortality risk stratification in ICU SE patients, enabling manual risk calculation without electronic computation.
- Publisher Full Text (DOI)
- Taking a clinical history in adolescents and adults presenting with seizures or epilepsy. [Journal Article]Epileptic Disord. 2026 Oct 10. [Online ahead of print]ED
- Despite advances in EEG, neuroimaging, and other diagnostic technologies, a carefully obtained clinical history remains the cornerstone of diagnosis, classification, and treatment planning. However, structured guidance on history-taking that integrates state-of-the-art evidence and the updated 2025 International League Against Epilepsy (ILAE) seizure classification is limited. We performed a revi…
- Publisher Full Text (DOI)
- Pragmatic screening for autoimmune-associated epilepsy in drug-resistant epilepsy of unknown etiology in resource-limited settings: A hypothesis-generating study. [Journal Article]Epileptic Disord. 2026 Oct 08. [Online ahead of print]ED
- CONCLUSIONS: In resource-limited settings, systematic use of accessible clinical and laboratory markers may help identify patients with higher pre-test probability of AAE. A pragmatic screening approach may improve diagnostic efficiency and support individualized decision-making when comprehensive antibody testing is not readily available.
- Publisher Full Text (DOI)
- Pharmaco-resistant focal epilepsy of undetermined origin responding to corticosteroids: A clinical vignette. [Case Reports]Epileptic Disord. 2026 Oct 08. [Online ahead of print]ED
- Publisher Full Text (DOI)